Lack of association of angiotensin I-converting enzyme gene polymorphism and premature myocardial infarction in Mauritian Indians

Clinical Genetics

Volumn 50, Issue 6, 1996, Pages 551-554

  Ramasawmy, Rajendranath ^a,b,c   Manraj, Meera ^b   Kotea, Navaratnam ^b   Shun, Nathalie Kok ^b   Genin, Emmanuelle ^a   Feingold, Josué ^a   Krishnamoorthy, Rajagopal ^a   Baligadoo, Sooriahnarain ^b  

^a INSERM   (France)

^b SSR Center for Medical Research   (Mauritius)

^c HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Angiotensin I converting enzyme; DNA; Mauritian Indians; Polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNIC GROUP; GENE DELETION; GENE FREQUENCY; GENE INSERTION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MAURITIUS; PRIORITY JOURNAL;

EID: 0030478727     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.1996.tb02737.x     Document Type: Article

References (22)

1. Bohn M, Berge KE, Bakken A, Erikssen J, Berg K. Insertion/ deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction. Clin Genet 1993: 44: 292-297.
2. Cambien F, Poirier O, Lecerf L, Evans A, Cambou J-P, Arveiller D, Luc G, Bard J-M, Bara L, Richard S, Tiret L, Amouyel P, Alhens-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992: 359: 641-644.
3. Friedlander Y, Kark JD, Stein Y. Family history of myocardial infarction as an independent risk factor for coronary heart disease. Br Heart J 1985: 53: 382-387.
4. Hamsten A, de Faire U. Risk factors for coronary artery disease in families of young men with myocardial infarction. Am J Cardiol 1987: 59: 14-19.
5. Katsuya T, Kolke G, Yee TW, Sharpe N, Jackson R, Norton R, Horiuchi M, Pratt RE, Dzau VJ, MacMahon S. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 1995: 345: 1600-1603.
6. Lindpainter K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, Lamotte F, Buring J, Hennekens CH. A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995: 332: 706-711.
7. Ludwig E, Cornelli PS, Anderson JL, Marshall HW, Lalouel J-M, Ward RH. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 1995: 91: 2120-2124.
8. Marian AJ, Yu QT, Workman R, Greve G, Roberts R. Angiotensin converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden death. Lancet 1993: 342: 1085-1086.
9. Miettinen H, Korpela K, Hämäläinen L, Kontula K. Polymorphisms of the apolipoprotein and angiotensin-converting enzyme gene as a risk factor for coronary heart disease. Hum Genet 1994: 94: 189-192.
10. Morris BJ, Zee RYL, Schrader AP. Different frequencies of angiotensin-converting enzyme genotypes in older hypertensive individuals. J Clin Invest 1994: 94: 1085-1089.
11. Nora JJ, Lortscher RH, Spangler RD, Nora AH, Kimberling WJ. Genetic-epidemiologic study of early-onset ischemic heart disease. Circulation 1980: 61: 503-508.
12. Ohishi M, Fujii K, Minamino T, Higaki J, Kamitani A, Rakugi H, Zhao Y, Mikami H, Miki T, Ogihara T. A potent genetic risk factor for restenosis. Nature Genet 1993: 5: 324-325.
13. Pfeffer MA, Braunwald E, Moyle LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH, Hawkins CM, on behalf of the SAVE investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. New Engl J Med 1992: 327: 669-677.
14. Raynolds MV, Bristow MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, Taft CS, Perryman MB. Angiotensin-converting enzyme DD genotypes in patients with ischemic or idiopathic dilated cardiomyopathy. Lancet 1993: 342: 1073-1075.
15. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP 1) (dipeptidyl carboxypeptidase 1). Nucl Acids Res 1992: 20: 1433.
16. Ruiz J, Blanché H, Cohen N, Velho G, Cambien F, Cohen D, Passa P, Froguel P. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1994: 91: 3662-3665.
17. Schunkert H, Hense H-W, Holmer SR, Stender M, Perz S, Keil U, Lorell BH, Riegger GAJ. Association between a deletion polymorphism and left ventricular hypertrophy. N Engl J Med 1994: 330: 1634-1638.
18. Shanmugam V, Sell KW, Saha BK. Mistyping ACE heterozygotes. PCR methods and application 1993: 3: 120-121.
19. Ten Kate LP, Borman H, Daiger SP, Motulsky AG. Familial aggregation of coronary heart disease and its relation to known genetic risk factors. Am J Cardiol 1982: 50: 945-953.
20. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New Engl J Med 1991: 325:293-302
21. Tiret L, Bonnardeaux A, Poirier O, Richard S, Marques-Vidal P, Evans A, Arveiler D, Luc G, Kee F. Ducimetière P, Soubrier F, Cambien F. Synergistic effects of angiotensin-converting enzyme and angiotensin II type I receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994: 344: 910-913.
22. Zhao Y, Higashimori K, Higaki J, Kamitani A, Ohishi M, Katsuya T, Miki T, Mikami H, Minamino T, Ogihara T. Significance of the deletion polymorphism of the angiotensin-converting enzyme gene as a risk factor for myocardial infarction in Japanese. Hypertens Res 1994: 17: 55-57.